Leading the Way in Life Science Technologies

GEN Exclusives

More »

March 1, Vol. 32, No. 5

  • Feature Articles

    • Modernizing Vaccine Production
    • Hannah Waters
    • Emerging bird and swine flu variants during the past decade haven’t turned into the epidemics some feared, but they have still sent a firm message to governments and drugmakers: Current manufacturing procedures are not ready to produce enough vaccine fast ... more »
    • Optimizing LC/MS for Drug Bioanalysis
    • Vicki Glaser
    • Bioanalysis of drugs in development is shifting toward high-sensitivity and high-throughput methodologies based on LC/MS platforms capable of drug and metabolite identification and quantification, with the ability to detect low-volume analytes and to discriminate between closely related molecules in complex ... more »
    • New Products Rolled Out at SLAS
    • Last month in San Diego, the Society for Laboratory Automation and Screening (SLAS) held its first conference and exhibition The meeting took the place of the former LabAutomation and SBS conferences In addition to lecture presentations, roundtables, and workshops, the ... more »
    • NGS Advances Spawn Novel Challenges
    • Greg Crowther, Ph.D.
    • One measure of the dramatic progress in next-generation sequencing is that scientists no longer want to talk about advances in instrumentation They would prefer to talk about other issues, including sample prep and analysisThese timely topics and more will be ... more »
    • Tackling Transfection Tactically
    • Josh P. Roberts
    • There are two functionally different types of DNA transfection (with a gray area between) On the one hand, stable transfections allow newly introduced genetic material to be passed down as part of the fixed genome On the other hand, transiently ... more »
    • Regenerative Medicine Back on Fast Track
    • Catherine Shaffer
    • After decades of controversy and frustratingly slow progress, the stem cell field seems poised for breakthroughs in a range of diseases One by one, obstacles such as tumorigenicity of embryonic stem cells and immune rejection of allogeneic transplants are giving ... more »